This is a discussion on Neublastin Enters Phase I Clinical Development As A Novel Treatment For Neuropathic Pain within the Emerging Spine Surgery Technologies forums, part of the Spine Surgery Support category; Neublastin Enters Phase I Clinical Development As A Novel Treatment For Neuropathic Pain 06 Sep 2009 NsGene A/S announced that ...
Neublastin Enters Phase I Clinical Development As A Novel Treatment For Neuropathic Pain
06 Sep 2009
NsGene A/S announced that Neublastin, a proprietary therapeutic protein that NsGene has out-licensed to Biogen Idec [NASDAQ: BIIB] in the field of peripheral nervous system disorders, has entered into Phase I clinical development for the treatment of neuropathic pain.Click here to read the full article on Medical News Today's website.
...snip...
Neublastin is a novel and potentially disease-modifying therapeutic protein for the treatment of neuropathic pain that afflicts millions of people worldwide. Neuropathic pain is a major debilitating consequence of nerve damage and the existing treatments are largely ineffective. Neuropathic pain is commonly caused by diabetes and herpes zoster infection. Other causes are amputation, failed back syndromes, cancer-induced nerve compression and chemotherapy...
Justin Averna
Founder & President, Spine Patient Society™
www.SpinePatientSociety.org
A 501(c)(3) Tax-Exempt Nonprofit & Charitable Organization
I'm here to help.
- 1994: Football Injury, Severe Hyperextension
- 1997: Snow Skiing Injury
- 3/7/1997: Laminotomy L4/L5
- 1999 & 2003: Motor Vehicle Accidents (not at fault both times) --> Grade V Annular Tears L4/L5 & L5/L6
- 11/15/2003: 2-Level ProDisc® L4/L5 & L5/L6*, *lumbosacral transitional vertebra --> Dr. Rudolf Bertagnoli
- 4/2008: 4.5 years pain-free before "new" leg pain
- 5/14/2009: Dynamic Stabilization System L4/L5, Dr. Rudolf Bertagnoli
Questions? Suggestions? Need help with registering, creating a signature, etc.?
justin (at) spinepatientsociety.org
Disclosure: I have no financial relationships with any surgeons, spine clinics, device manufacturers, pharmaceutical companies, hospitals, etc. -- the SPS Board of Directors serve without compensation.
Bookmarks